Simultaneous analysis of wall motion and coronary flow reserve of the left anterior descending coronary artery by transthoracic doppler echocardiography during dipyridamole stress echocardiography.

[1]  E Picano,et al.  Diagnosis of myocardial ischemia in hypertensive patients. , 2001, Journal of hypertension.

[2]  M. Takeuchi,et al.  Assessment of coronary flow velocity with transthoracic Doppler echocardiography during dobutamine stress echocardiography. , 2001, Journal of the American College of Cardiology.

[3]  H. Seo,et al.  Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison among adenosine, standard-dose dipyridamole, and high-dose dipyridamole. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  H. Lethen,et al.  Noninvasive assessment of coronary flow reserve with transthoracic signal-enhanced Doppler echocardiography. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  C Caiati,et al.  New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. , 1999, Circulation.

[6]  S. Brecker.  Stress Echocardiography, Picano E. (Ed.). Springer (1997) , 1998 .

[7]  T Akasaka,et al.  Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. , 1998, Journal of the American College of Cardiology.

[8]  T Akasaka,et al.  Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. , 1998, Circulation.

[9]  L Crouse,et al.  Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 1998, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  F. Fernández‐Avilés,et al.  Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment. , 1996, Chest.

[11]  D. Kawanishi,et al.  Transesophageal assessment of coronary flow velocity reserve during "regular" and "high"-dose dipyridamole stress testing. , 1996, The American journal of cardiology.

[12]  G. Minardi,et al.  The atropine factor in pharmacologic stress echocardiography , 1996 .

[13]  Thomas H. Marwick.  Cardiac stress testing & imaging : a clinician's guide , 1996 .

[14]  T. Marwick,et al.  Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: a study with transesophageal echocardiography and positron emission tomography with oxygen 15 water. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  A. Nitenberg,et al.  Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results. , 1995, European heart journal.

[16]  K. Chan,et al.  Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  J. Seward,et al.  Stress echocardiography. Part I. Exercise echocardiography: techniques, implementation, clinical applications, and correlations. , 1995, Mayo Clinic proceedings.

[18]  A. Djordjević-Dikić,et al.  Stress Echocardiography in the Detection of Myocardial Ischemia: Head‐to‐Head Comparison of Exercise, Dobutamine, and Dipyridamole Tests , 1994, Circulation.

[19]  M. Verani,et al.  Pharmacologic stress testing: Mechanism of action, hemodynamic responses, and results in detection of coronary artery disease , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[20]  H. Feigenbaum.  Evolution of stress echocardiography. , 1999, Echocardiography.

[21]  F. Rengo,et al.  Effect of beta-adrenoceptor blockade on dipyridamole-induced myocardial asynergies in coronary artery disease. , 1992, The American journal of cardiology.

[22]  E. Picano,et al.  Stress echocardiography. From pathophysiological toy to diagnostic tool. , 1992, Circulation.

[23]  E. Picano,et al.  Inhibition of Dipyridamole‐Induced Ischemia by Antianginal Therapy in Humans: Correlation With Exercise Electrocardiography , 1991, Circulation.

[24]  K. Gould,et al.  Coronary flow reserve as a physiologic measure of stenosis severity. , 1990, Journal of the American College of Cardiology.

[25]  Hoffman Ji.  A critical view of coronary reserve. , 1987, Circulation.

[26]  G. Beller,et al.  Sensitivity, specificity, and prognostic significance of noninvasive testing for occult or known coronary disease. , 1987, Progress in cardiovascular diseases.

[27]  C. White,et al.  Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? , 1984, The New England journal of medicine.